BIIB - BIOGEN INC.
143.66
-7.050 -4.907%
Share volume: 1,838,069
Last Updated: 03-11-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$150.71
-7.05
-0.05%
View ratios
| Fiscal Date | 12-31-2023 | 12-31-2023 | 03-31-2024 | 03-31-2024 | 06-30-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2023 | Q4 2023 | Q1 2024 | Q1 2024 | Q2 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 02-12-2025 | 02-14-2024 | 04-24-2024 | 04-24-2024 | 08-01-2024 | 08-01-2024 | 10-30-2024 | 02-12-2025 | |
| Assets | |||||||||
| Total Assets | 26.845 B | 26.845 B | 26.568 B | 26.568 B | 26.804 B | 26.804 B | 28.313 B | 28.049 B | |
| Current Assets | 6.859 B | 6.859 B | 6.756 B | 6.756 B | 7.109 B | 7.109 B | 6.831 B | 7.457 B | |
| Inventories | 2.527 B | 2.527 B | 2.517 B | 2.517 B | 2.506 B | 2.506 B | 2.469 B | 2.461 B | |
| Other Current Assets | 1.618 B | 1.182 B | 1.165 B | 1.165 B | 615.300 M | 615.300 M | 674.000 M | 1.217 B | |
| Short Term Investments | 0.000 | 1.182 B | 0.000 | 1.165 B | 0.000 | 615.300 M | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 2.100 B | 0.000 | 2.000 B | 0.000 | 2.078 B | 0.000 | 0.000 | |
| Current Cash | 1.050 B | 1.050 B | 1.074 B | 1.074 B | 1.909 B | 1.909 B | 1.699 B | 2.375 B | |
| Total Non-current Assets | 0.000 | 19.986 B | 0.000 | 19.811 B | 0.000 | 19.696 B | 0.000 | 0.000 | |
| Property Plant Equipment | 3.310 B | 3.310 B | 3.275 B | 3.275 B | 3.249 B | 3.249 B | 3.211 B | 3.181 B | |
| Other Assets | 16.676 B | 745.000 M | 16.536 B | 697.600 M | 16.446 B | 681.500 M | 18.272 B | 17.411 B | |
| Intangible Assets | 0.000 | 8.363 B | 0.000 | 8.285 B | 0.000 | 8.233 B | 0.000 | 0.000 | |
| Goodwill | 0.000 | 6.219 B | 0.000 | 6.227 B | 0.000 | 6.227 B | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 26.845 B | 26.845 B | 26.568 B | 26.568 B | 26.804 B | 26.804 B | 28.313 B | 28.049 B | |
| Total liabilities | 12.045 B | 12.045 B | 11.355 B | 11.355 B | 10.915 B | 10.915 B | 11.954 B | 11.333 B | |
| Total current liabilities | 3.434 B | 3.434 B | 3.223 B | 3.223 B | 3.108 B | 3.108 B | 5.425 B | 5.529 B | |
| Accounts Payable | 403.300 M | 403.300 M | 387.000 M | 387.000 M | 354.500 M | 354.500 M | 422.700 M | 424.200 M | |
| Other liabilities | 1.181 B | 781.100 M | 1.184 B | 777.100 M | 924.200 M | 556.700 M | 1.101 B | 1.067 B | |
| Current long term debt | 0.000 | 150.000 M | 0.000 | 250.000 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 6.788 B | 6.788 B | 6.290 B | 6.290 B | 6.292 B | 6.292 B | 4.546 B | 4.547 B | |
| Other liabilities | 1.181 B | 781.100 M | 1.184 B | 777.100 M | 924.200 M | 556.700 M | 1.101 B | 1.067 B | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 14.799 B | 14.799 B | 15.213 B | 15.213 B | 15.889 B | 15.889 B | 16.359 B | 16.716 B | |
| Common stock | 302.600 M | 144.900 M | 329.600 M | 145.200 M | 407.600 M | 145.600 M | 488.600 M | 569.500 M | |
| Retained earnings | 17.628 B | 17.628 B | 18.021 B | 18.021 B | 18.605 B | 18.605 B | 18.993 B | 19.260 B |